Top Biotechnology companies in Netherlands by Shareholders' Equity
Netherlands
# |
Name |
Shareholders' Equity |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 4.10 B
|
Dec. 31, 2023 | USD 673.61 | 1.66% |
|
Netherlands |
|
| 2 |
USD 3.81 B
|
Dec. 31, 2023 | USD 45.57 | -0.94% |
|
Netherlands |
|
| 3 |
USD 702.21 M
|
Dec. 31, 2023 | USD 22.92 | 2.26% |
|
Netherlands |
|
| 4 |
USD 423.89 M
|
Dec. 31, 2023 | USD 16.00 | -2.50% |
|
Netherlands |
|
| 5 |
USD 356.34 M
|
Dec. 31, 2023 | USD 39.01 | -3.56% |
|
Netherlands |
|
| 6 |
USD 288.39 M
|
Dec. 31, 2023 | USD 23.67 | -3.70% |
|
Netherlands |
|
| 7 |
USD 218.78 M
|
Dec. 31, 2023 | USD 9.93 | 5.98% |
|
Netherlands |
|
| 8 |
USD 207.67 M
|
Dec. 31, 2023 | USD 13.23 | -4.06% |
|
Netherlands |
|
| 9 |
USD 51.18 M
|
Dec. 31, 2023 | USD 0.98 | -1.01% |
|
Netherlands |
|
| 10 |
USD 45.68 M
|
Dec. 31, 2023 | USD 2.26 | -0.44% |
|
Netherlands |
Frequently Asked Questions
-
Which Biotechnology company in Netherlands has the highest Shareholders' Equity ?
The Biotechnology company in Netherlands with the highest Shareholders' Equity is argenx SE (Brussels Stock Exchange: ARGX.BR) at USD 4.10 B.
-
Which Biotechnology company in Netherlands has the lowest Shareholders' Equity ?
The Biotechnology company in Netherlands with the lowest Shareholders' Equity is ProQR Therapeutics N.V. (NasdaqCM: PRQR) at USD 45.68 M.
-
What are the top 10 Biotechnology companies in Netherlands by Shareholders' Equity ?
The top 10 Biotechnology companies in Netherlands by Shareholders' Equity are argenx SE, Qiagen N.V., Corbion N.V., Pharvaris N.V., Merus N.V., NewAmsterdam Pharma Company N.V., Pharming Group N.V., uniQure N.V., LAVA Therapeutics N.V. and ProQR Therapeutics N.V..
-
What are the bottom 10 Biotechnology companies in Netherlands by Shareholders' Equity ?
The bottom 10 Biotechnology companies in Netherlands by Shareholders' Equity are ProQR Therapeutics N.V., LAVA Therapeutics N.V., uniQure N.V., Pharming Group N.V., NewAmsterdam Pharma Company N.V., Merus N.V., Pharvaris N.V., Corbion N.V., Qiagen N.V. and argenx SE.